Ovarian Cancer Vaccine Clinical Trial Begins At Cancer Treatment Centers Of America

Cancer Treatment Centers of America (CTCA), a leading provider of innovative cancer care for patients living with complex and advanced-stage disease, has begun accepting patients for an ovarian

cancer vaccine clinical trial. The Phase I/II study, recently reviewed and cleared by the U.S.

Original post by Women’s Health / Gynecology News From Medical News Today

Share and Enjoy: These icons link to social bookmarking sites where readers can share and discover new web pages.
  • Digg
  • del.icio.us
  • Netvouz
  • DZone
  • ThisNext
  • MisterWong
  • Wists
  • BlinkList
  • Furl
  • IndianPad
  • Netscape
  • Reddit
  • Simpy
  • Spurl
  • StumbleUpon
  • Technorati
Related Articles
  • AVAX Technologies Announces Initiation Of Clinical Study With Autologous Ovarian Cancer Vaccine (OVax)
  • Cancer Vaccine Triggers Immune System In Ovarian Cancer Study
  • Vermillion Completes Clinical Trial Enrollment For Ovarian Cancer Triage Test
  • Evaluation Of Brain Cancer Vaccine Clinical Trial Is Underway At NYU
  • Northwest Biotherapeutics Conducting Ovarian Cancer Clinical Trial With DCVax(R)-L At University Of Pennsylvania
  • No comments yet. Be the first.

    Leave a reply

    You must be logged in to post a comment.